229 related articles for article (PubMed ID: 33607613)
1. Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease.
Löser J; Luthardt J; Rullmann M; Weise D; Sabri O; Meixensberger J; Hesse S; Winkler D
J Neurosurg; 2021 Feb; 135(5):1429-1435. PubMed ID: 33607613
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
3. Increased anteroventral striatal dopamine transporter and motor recovery after subthalamic deep brain stimulation in Parkinson's disease.
Nozaki T; Sugiyama K; Asakawa T; Namba H; Yokokura M; Terada T; Bunai T; Ouchi Y
J Neurosurg; 2022 Aug; 137(2):468-478. PubMed ID: 34972089
[TBL] [Abstract][Full Text] [Related]
4. Correlation of response to subthalamic deep brain stimulation in Parkinson's disease patients with striatal dopamine transporter density on 99mtc-TRODAT-1 SPECT.
Ghaedian T; Razmkon A; Kalhor L; Ostovan VR; Yousefi O; Rezaei R; Hossein-Tehrani MR; Rakhsha A
Neurol Res; 2023 Jun; 45(6):505-509. PubMed ID: 36573915
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's Disease Motor Subtypes Show Different Responses to Long-Term Subthalamic Nucleus Stimulation.
Xu C; Zhuang P; Hallett M; Zhang Y; Li J; Li Y
Front Hum Neurosci; 2018; 12():365. PubMed ID: 30337863
[No Abstract] [Full Text] [Related]
7. Effect of unilateral subthalamic deep brain stimulation in highly asymmetrical Parkinson's disease: 7-year follow-up.
Ehm G; Kim HJ; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Lim YH; Jeon B; Paek SH
J Neurosurg; 2018 Nov; 131(5):1508-1513. PubMed ID: 30497175
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation on Motor Subtypes in Parkinson's Disease.
Fan S; Liu D; Shi L; Meng F; Fang H; Liu H; Zhang H; Yang A; Zhang J
World Neurosurg; 2022 Aug; 164():e245-e255. PubMed ID: 35489598
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of subthalamic nucleus deep brain stimulation on freezing of gait in Parkinson's disease.
Kim R; Kim HJ; Shin C; Park H; Kim A; Paek SH; Jeon B
J Neurosurg; 2019 Jan; 131(6):1797-1804. PubMed ID: 30641837
[TBL] [Abstract][Full Text] [Related]
10. Use of
Dongfang C; Xianzhi M; Cen L; Zhongke H
Hell J Nucl Med; 2022; 25(3):247-252. PubMed ID: 36507880
[TBL] [Abstract][Full Text] [Related]
11. SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.
Nunta-Aree S; Sitthinamsuwan B; Boonyapisit K; Pisarnpong A
J Med Assoc Thai; 2010 May; 93(5):529-40. PubMed ID: 20524438
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson's disease: A pilot study of DATSCAN for subthalamic deep brain stimulation.
Nakajima A; Shimo Y; Sekimoto S; Kamagata K; Jo T; Oyama G; Umemura A; Hattori N
J Neurol Sci; 2018 Feb; 385():134-139. PubMed ID: 29406893
[TBL] [Abstract][Full Text] [Related]
13. Effects of STN-DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson's disease.
Luo G; Shi X; Jiang L; Wu L; Yi C; Xian W; Liu Y; Wen F; Qian H; Chen J; Fu X; Liu J; Zhang X; Chen L
Brain Behav; 2023 Aug; 13(8):e3172. PubMed ID: 37459244
[TBL] [Abstract][Full Text] [Related]
14. Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome.
van Horne CG; Quintero JE; Slevin JT; Anderson-Mooney A; Gurwell JA; Welleford AS; Lamm JR; Wagner RP; Gerhardt GA
J Neurosurg; 2018 Dec; 129(6):1550-1561. PubMed ID: 29451447
[TBL] [Abstract][Full Text] [Related]
15. Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up.
Hesse S; Strecker K; Winkler D; Luthardt J; Scherfler C; Reupert A; Oehlwein C; Barthel H; Schneider JP; Wegner F; Meyer P; Meixensberger J; Sabri O; Schwarz J
J Neurol; 2008 Jul; 255(7):1059-66. PubMed ID: 18446306
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
17. Clinical factors and dopamine transporter availability for the prediction of outcomes after globus pallidus deep brain stimulation in Parkinson's disease.
Lee SH; Kim M; Lee J; Kim JW; Kim MS; Jo S; Jeon SR; Chung SJ
Sci Rep; 2022 Oct; 12(1):16870. PubMed ID: 36207312
[TBL] [Abstract][Full Text] [Related]
18. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson's disease: 5 years and beyond.
Tsuboi T; Lemos Melo Lobo Jofili Lopes J; Moore K; Patel B; Legacy J; Ratajska AM; Bowers D; Eisinger RS; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
J Neurosurg; 2020 Oct; 135(2):601-610. PubMed ID: 33035998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
